Autoimmune Disorders

Newest Autoimmune Disorders Information

6 Best Peptides for Ankylosing Spondylitis

Ankylosing spondylitis is one of the more complex conditions people bring to peptide research, and the field of compounds being used or discussed for it is wider than most guides acknowledge. This article covers six peptides that appear consistently in AS community protocols and discussion, from BPC-157 and its gut-joint axis rationale to Tirzepatide, an FDA-approved peptide drug being used off-label by AS patients for its anti-inflammatory effects. No peptide has been tested in a human clinical trial specifically for AS as of 2026, so each entry is honest about where its evidence stands: some compounds have preclinical animal data in spondyloarthritis models, some rest on user-reported community experience, and a few have both. The compounds are ordered by how prominently each appears in research and real-world AS-specific use, not as a ranking of which is best for any individual.

Autoimmune Disorders 11 min read

6 Best Peptides for Lupus (SLE)

Six peptides stand out in the lupus (SLE) conversation in 2026, ranging from P140 (Lupuzor), the only compound to complete a Phase IIb randomized controlled trial specifically in SLE patients, to off-label options used in patient communities for joint pain, inflammation, and physical recovery. The evidence base across this list varies enormously: one compound has published human trial data, several have no SLE-specific clinical research at all, and a couple carry important safety considerations specific to autoimmune disease. These entries are ordered by how prominently each compound appears in the research and in documented real-world use for lupus, not as a ranking of one being better than another for any individual.

Autoimmune Disorders 12 min read

7 Best Peptides for Rheumatoid Arthritis

Rheumatoid arthritis sits at the harder end of the peptide landscape: the immune dysfunction driving the disease is complex, no peptide is FDA-approved for RA, and the evidence behind most commonly used compounds is preclinical or community-reported rather than clinical. That reality does not stop people from using them. This guide covers the seven peptides people actually reach for or actively discuss for RA, from Thymosin Alpha-1 and KPV to BPC-157, TB-500, and the research-stage compounds VIP and PEPITEM that science has moved further along but that are not yet available in practice. The entries are ordered by how prominently each compound appears in research and real-world RA discussions, not as a ranking of one being better than another for any individual.

Autoimmune Disorders 13 min read

4 Best Peptides for Guillain-Barre Syndrome

Guillain-Barre Syndrome sits at a difficult intersection for peptide research: no compound has completed a human clinical trial for this condition, yet a small set of peptides is genuinely being discussed and researched by GBS survivors, caregivers, and biohackers because of their nerve-repair and anti-inflammatory biology. This guide covers four compounds, EV576, BPC-157, Cerebrolysin, and TB-500, ordered by how prominently each appears in the research and in documented discussion around GBS, not as a recommendation of one over another. The evidence for every entry is stated plainly, from patent-stage preclinical data to user-reported interest with no confirmed outcomes. GBS is a medical emergency, and nothing here is a substitute for intravenous immunoglobulin or plasma exchange.

Autoimmune Disorders 9 min read

5 Best Peptides for Myasthenia Gravis

Five peptides come up in the Myasthenia Gravis landscape, ranging from zilucoplan, the only FDA-approved peptide therapy for the condition with solid Phase III trial data, to thymic immunomodulators, an experimental antigen-specific research category, and one anecdotally reported compound with no clinical evidence for MG. The field is unusually uneven: one compound has a completed randomized controlled trial and regulatory approval, while the rest operate on mechanistic reasoning, preclinical data, or a single user account. The entries are numbered by how prominently each appears in MG-specific research and documented use, not as a recommendation of one compound over another, and the personalized decision for any individual belongs with a neuromuscular specialist and the MyPeptidePal app.

Autoimmune Disorders 11 min read

6 Best Peptides for Autoimmune Disorders

Six peptides stand out as the compounds people most commonly use or actively discuss for autoimmune disorders in 2026, ranging from Thymosin Alpha-1 with its three-decade international track record to Lupuzor, the most clinically advanced purpose-built autoimmune peptide ever trialed. The field spans one FDA-approved therapy, several off-label compounds used through functional medicine and compounding channels, and others whose evidence base is still largely preclinical or community-reported. Entries are ordered by how prominently each compound appears in research and documented real-world use, not as a recommendation of one over another, and the right choice depends heavily on specific diagnosis, current medications, and practitioner guidance.

Autoimmune Disorders 11 min read

dont Spend six hours researching every peptide.

About MyPeptidePal

MyPeptidePal is the world's largest peptide knowledge base and your personal AI peptide expert in one. Trained on every published study and over 10,000 protocols, it gets smarter every day, learning from new research and a community actively running and tracking their own. Build a personalized protocol in 60 seconds, get dosing math you can trust, find vetted suppliers, set auto-pilot reminders, and get straight answers on peptides, health, fitness, and longevity, all in one place. Try for FREE Here, no credit card required.